MedPath

The influence of dropsize of tropicamide eyedrops on pupildilatio

Conditions
Pupil diagnostics
Therapeutic area: Not possible to specify
Registration Number
EUCTR2012-005219-18-NL
Lead Sponsor
St. Elisabeth Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

age between18-64 years
informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 28
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

eye disease, risk factors for angle-closure glaucoma, previous eyetrauma/surgery, dioptric value >+6, cardiac disease, diabetes, medication for the eye, medication influencing pupildiameter, substance abuse, (possible) pregnancy, breastfeeding

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Is the degree of pupildilation, achieved after administrating a 4.5 microliter microdrop tropicamide 0.5% equivalent to the pupildilation after a regular 30 microliter eydrop tropicamide 0.5% in healthy volunteers?<br><br>;Secondary Objective: Is there a subjective difference in the degree of physical discomfort, experienced after administration of a microdrop compared to a regular eyedrop?<br>Qualitative evaluation of the mydriatic reponse/time curves of both the microdrop and the regular eyedrop.;Primary end point(s): Within-subject pupildilation (compared to baseline) of a regular eyedrop and a microdrop at t=40 min.;Timepoint(s) of evaluation of this end point: 40 minutes after eyedrop administration
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): Physical discomfort, experienced after administration of a microdrop and a regular eyedrop.<br>Qualitative evaluation of the mydriatic reponse/time curves of both the microdrop and the regular eyedrop.;Timepoint(s) of evaluation of this end point: following both studysessions
© Copyright 2025. All Rights Reserved by MedPath